Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001144204-16-124443
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-19 17:15:41
Reporting Period:
2016-09-15
Filing Date:
2016-09-19
Accepted Time:
2016-09-19 17:15:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557746 Aclaris Therapeutics Inc. ACRS () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315082 Ra Capital Healthcare Fund Lp C/o Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
1346824 Ra Capital Management, Llc C/o Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
1384859 Peter Kolchinsky C/o Ra Capital Management, Llc
20 Park Plaza, Suite 1200
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-09-15 20,000 $24.04 2,607,719 No 4 S Indirect See Footnote
Common Stock Disposition 2016-09-15 273,000 $24.00 2,334,719 No 4 S Indirect See Footnote
Common Stock Disposition 2016-09-15 58,950 $24.20 2,275,769 No 4 S Indirect See Footnote
Common Stock Disposition 2016-09-16 150,000 $24.50 2,125,769 No 4 S Indirect See Footnote
Common Stock Disposition 2016-09-16 23,600 $24.54 2,102,169 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. RA Capital Management, LLC (the "Adviser") and Peter Kolchinsky disclaim beneficial ownership of the reported securities for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934 (the "Exchange Act") in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and, therefore, disclaim any obligation to report ownership of or transactions in the reported securities under Section 16a of the Exchange Act. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Exchange Act, the beneficial owner of any of the securities reported herein.
  2. The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund") and an account owned by Blackwell Partners, LLC - Series A (the "Blackwell Account"). Following the reported transactions, the Fund held 1,770,522 shares and the Blackwell Account held 331,647 shares. The Adviser is the general partner of the Fund and the investment adviser of the Blackwell Account. Mr. Kolchinsky is the sole manager of the Adviser. In their respective capacities, each of Mr. Kolchinsky and the Adviser may be deemed to beneficially own the reported securities for purposes of Section 13(d) of the Exchange Act.